Enteral And Parenteral Medical Nutrition Market Scope And Analysis

Report Code : TIPRE00029916
Category : Life Sciences

No. of Pages : 150

Buy Now

Enteral and Parenteral Medical Nutrition Market Scope, Analysis, and Trends by 2028

Buy Now

Enteral and Parenteral Medical Nutrition Market Report Scope

Report Attribute	Details
Market size in 2023	US$ 18,377.13 Million
Market Size by 2031	US$ 32,408.02 Million
Global CAGR (2023 - 2031)	7.3%
Historical Data	2021-2022
Forecast period	2024-2031
Segments Covered	By Indication Elderly Diabetes Cancer Gastrointestinal Disorders Respiratory Disorders Alzheimers Disease Dementia Renal Disease Liver Failure Post COVID-19 By Nutrition Type Supplemental Sole Source By Form Liquid Powder Semi Solid By Product Type General Disease Specific
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Abbott Laboratories Nestle SA Nutricia International BV Medtrition Inc Fresenius Kabi AG B Braun SE Smartfish AS Nutrisens SAS AYMES International Ltd Medifood International SA

Enteral and Parenteral Medical Nutrition Market News and Recent Developments

The enteral and parenteral medical nutrition market is evaluated by gathering qualitative and quantitative data post post-post-primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the enteral and parenteral medical nutrition market are listed below:

Fresenius Kabi’s SMOFlipid lipid injectable emulsion received US Food and Drug Administration (FDA) approval. The emulsion is used to provide parenteral nutrition to pediatric patients, including term and preterm neonates, which makes it the first and only four-oil lipid emulsion for parenteral nutrition patients of every age. (Source: Fresenius Kabi, Press Release, March 2022)
Abbott launched Similac 360 Total Care, the company's next generation of infant formula with human milk oligosaccharides (HMO). It is the first and only infant formula in the US with a blend of five various prebiotic HMOs (only found together in breast milk). Similac 360 Total Care is developed to provide nutrition to support whole health and progress in babies, including the development of the immune system, digestive system, and brain. (Source: Abbott, Press Release, November 2021)

Enteral and Parenteral Medical Nutrition Market Report Coverage and Deliverables

The “Enteral and Parenteral Medical Nutrition Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

Enteral and parenteral medical nutrition market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Enteral and parenteral medical nutrition market trends as well as market dynamics such as drivers, restraints, and key opportunities
Detailed PEST and SWOT analysis
Enteral and parenteral medical nutrition market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the enteral and parenteral medical nutrition market
Detailed company profiles